Bicycle Therapeutics Stock (NASDAQ: BCYC) stock price, news, charts, stock research, profile.
Open | $22.160 |
Close | $21.820 |
Volume / Avg. | 718.891K / 383.871K |
Day Range | 21.700 - 22.995 |
52 Wk Range | 12.540 - 28.910 |
Market Cap | $828.448M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | 7.37% |
Days to Cover | 6.67 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Bicycle Therapeutics (NASDAQ: BCYC) through any online brokerage.
Other companies in Bicycle Therapeutics’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Cabaletta Bio (NASDAQ:CABA), 89bio (NASDAQ:ETNB), Zentalis Pharma (NASDAQ:ZNTL) and Sage Therapeutics (NASDAQ:SAGE).
The latest price target for Bicycle Therapeutics (NASDAQ: BCYC) was reported by Needham on Wednesday, April 10, 2024. The analyst firm set a price target for 43.00 expecting BCYC to rise to within 12 months (a possible 97.07% upside). 25 analyst firms have reported ratings in the last year.
The stock price for Bicycle Therapeutics (NASDAQ: BCYC) is $21.82 last updated April 17, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Bicycle Therapeutics.
Bicycle Therapeutics’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for Bicycle Therapeutics.
Bicycle Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.